GoAI
Get started
Doximity, Inc. logo

Doximity, Inc.

DOCS

NYSEHealthcareMedical - Healthcare Information Services

Open in GoAI

Previous close

$25.33

−$0.61 · -2.35%

Aug 21, 4:00 PM ET

DOCS company overview

Regular session · ET · Market data may be delayed.

GoAI snapshot

AI-powered factor overview

Jul 10, 2026

GoAI score

Hold

Wait — insufficient conviction to act

Valuation

85

Deep Value

Momentum

26

Weakening

Sentiment

65

Bullish

Risk resilience

41

Elevated Risk

Full GoAI research

Thesis, catalysts, evidence, and risk analysis.

View full GoAI research

AI-generated, informational only, and not investment advice.

Company profile

Company website

Doximity, Inc. provides a digital platform, hosted in the cloud, specifically designed for healthcare practitioners throughout the United States. This platform delivers a suite of specialized tools, empowering its members to connect with peers, streamline patient treatment, conduct remote consultations, access current medical information and research, and advance their professional careers. Its primary clientele consists of pharmaceutical companies and healthcare organizations. Established in 2010, the entity initially operated as 3MD Communications, Inc. before rebranding to Doximity, Inc. in June of that year. The company's corporate headquarters are situated in San Francisco, California.

Industry
Medical - Healthcare Information Services
Sector
Healthcare
Headquarters
US
CEO
Jeffrey A. Tangney
Listed since
Jun 24, 2021
Employees
880

Market position

Day range

Current $25.33

52-week range

Current $25.33

Open
$25.84
Previous close
$25.94
Volume
2.61M
0.54× average
Average volume
4.87M
Average daily volume
Market cap
4.74B USD
Beta
1.21
Market reference 1
50-day average
$22.1766
+14.22% above average
200-day average
$30.3111
-16.43% below average

Financials

Financial snapshot

Latest / TTM

Valuation & yield

Enterprise value
4.15B USD
P/E (TTM)
28.46×
P/B (TTM)
5.05×
P/S (TTM)
7.23×
EV / EBITDA
15.69×
Earnings yield
4.50%
Free cash flow yield
7.29%
Dividend yield
0.00%

Profitability & efficiency

Gross margin
88.07%
Operating margin
29.60%
Net margin
25.48%
Return on equity
20.62%
Return on assets
17.45%
Return on invested capital
17.36%

Financial health

Debt / equity
0.01×
Current ratio
6.09×

Financial statements

Margin trends

Profitability as a percentage of reported revenue.

Gross marginOperating marginNet margin
Gross, operating, and net margin trends97%71%46%21%Gross margin, FY2022: 88.42%Gross margin, FY2023: 87.24%Gross margin, FY2024: 89.34%Gross margin, FY2025: 90.20%Gross margin, FY2026: 89.09%Operating margin, FY2022: 33.05%Operating margin, FY2023: 29.86%Operating margin, FY2024: 34.47%Operating margin, FY2025: 39.94%Operating margin, FY2026: 33.33%Net margin, FY2022: 45.05%Net margin, FY2023: 26.92%Net margin, FY2024: 31.04%Net margin, FY2025: 39.13%Net margin, FY2026: 30.40%FY2022FY2023FY2024FY2025FY2026
Gross margin FY2022 88.42%. Gross margin FY2023 87.24%. Gross margin FY2024 89.34%. Gross margin FY2025 90.20%. Gross margin FY2026 89.09%. Operating margin FY2022 33.05%. Operating margin FY2023 29.86%. Operating margin FY2024 34.47%. Operating margin FY2025 39.94%. Operating margin FY2026 33.33%. Net margin FY2022 45.05%. Net margin FY2023 26.92%. Net margin FY2024 31.04%. Net margin FY2025 39.13%. Net margin FY2026 30.40%.

Income trends

Revenue

644.86M USD+13.05%

Operating income

214.92M USD-5.65%

Net income

196.05M USD-12.16%
Income trends across reported periods698.07M USD485.25M USD272.43M USD59.61M USDRevenue, FY2022: 343.55M USDRevenue, FY2023: 419.05M USDRevenue, FY2024: 475.42M USDRevenue, FY2025: 570.4M USDRevenue, FY2026: 644.86M USDOperating income, FY2022: 113.54M USDOperating income, FY2023: 125.11M USDOperating income, FY2024: 163.88M USDOperating income, FY2025: 227.8M USDOperating income, FY2026: 214.92M USDNet income, FY2022: 154.78M USDNet income, FY2023: 112.82M USDNet income, FY2024: 147.58M USDNet income, FY2025: 223.19M USDNet income, FY2026: 196.05M USDFY2022FY2023FY2024FY2025FY2026
Revenue FY2022 343.55M USD. Revenue FY2023 419.05M USD. Revenue FY2024 475.42M USD. Revenue FY2025 570.4M USD. Revenue FY2026 644.86M USD. Operating income FY2022 113.54M USD. Operating income FY2023 125.11M USD. Operating income FY2024 163.88M USD. Operating income FY2025 227.8M USD. Operating income FY2026 214.92M USD. Net income FY2022 154.78M USD. Net income FY2023 112.82M USD. Net income FY2024 147.58M USD. Net income FY2025 223.19M USD. Net income FY2026 196.05M USD.
Metric (USD)FY2026FY2025FY2024FY2023FY2022
Revenue644.86M USD570.4M USD475.42M USD419.05M USD343.55M USD
Cost of goods sold70.33M USD55.87M USD50.67M USD53.49M USD39.79M USD
Gross profit574.54M USD514.53M USD424.75M USD365.56M USD303.76M USD
Research and development130.7M USD93.04M USD81.98M USD80.19M USD62.35M USD
Selling, general, and administrative228.92M USD191.38M USD170.96M USD160.27M USD127.88M USD
Operating expenses359.62M USD286.73M USD260.88M USD240.45M USD190.23M USD
Interest income35.7M USD35.85M USD21.66M USD9.29M USD2.15M USD
Depreciation and amortization14.38M USD10.66M USD10.27M USD10.28M USD5.04M USD
Operating income214.92M USD227.8M USD163.88M USD125.11M USD113.54M USD
Net income196.05M USD223.19M USD147.58M USD112.82M USD154.78M USD

Company facts updated Aug 24, 2026.

Earnings

EPS beat rate
82%
9 beats, 2 misses, 0 met estimates
Average EPS surprise
+19.52%
11 comparable reports
Latest EPS result
0.29
Estimate 0.3 · Miss by 4.29%

EPS: actual versus estimate

Recent quarterly results

ActualEstimate
Quarterly EPS actual values compared with estimates0.50.410.310.22Q1 '25BeatQ2 '25BeatQ3 '25BeatQ4 '25BeatQ1 '26BeatQ2 '26MissQ3 '26MissQ4 '26Estimate
Q1 2025, reported Feb 6, 2025: actual 0.45, estimate 0.31, surprise +45.16%, Beat. Q2 2025, reported May 15, 2025: actual 0.38, estimate 0.272, surprise +39.91%, Beat. Q3 2025, reported Aug 7, 2025: actual 0.36, estimate 0.302, surprise +19.36%, Beat. Q4 2025, reported Nov 6, 2025: actual 0.45, estimate 0.379, surprise +18.83%, Beat. Q1 2026, reported Feb 5, 2026: actual 0.46, estimate 0.44, surprise +4.55%, Beat. Q2 2026, reported May 13, 2026: actual 0.26, estimate 0.28, surprise -7.14%, Miss. Q3 2026, reported Aug 6, 2026: actual 0.29, estimate 0.303, surprise -4.29%, Miss. Q4 2026, reported Nov 5, 2026: actual —, estimate 0.34, surprise —, Comparison unavailable.

Revenue: actual versus estimate

Recent quarterly results

ActualEstimate
Quarterly Revenue actual values compared with estimates192.46M170.41M148.37M126.32MQ1 '25BeatQ2 '25BeatQ3 '25BeatQ4 '25BeatQ1 '26BeatQ2 '26BeatQ3 '26BeatQ4 '26Estimate
Q1 2025, reported Feb 6, 2025: actual 168.6M USD, estimate 134.14M USD, surprise +25.69%, Beat. Q2 2025, reported May 15, 2025: actual 138.29M USD, estimate 133.73M USD, surprise +3.41%, Beat. Q3 2025, reported Aug 7, 2025: actual 145.91M USD, estimate 139.53M USD, surprise +4.57%, Beat. Q4 2025, reported Nov 6, 2025: actual 168.53M USD, estimate 157.9M USD, surprise +6.73%, Beat. Q1 2026, reported Feb 5, 2026: actual 185.05M USD, estimate 181.63M USD, surprise +1.89%, Beat. Q2 2026, reported May 13, 2026: actual 145.37M USD, estimate 144.03M USD, surprise +0.93%, Beat. Q3 2026, reported Aug 6, 2026: actual 156.62M USD, estimate 151.77M USD, surprise +3.19%, Beat. Q4 2026, reported Nov 5, 2026: actual —, estimate 170.57M USD, surprise —, Comparison unavailable.

DOCS peers

Eli Lilly and Company logo

LLY

Eli Lilly and Company

$1,254.77

+0.83%

Johnson & Johnson logo

JNJ

Johnson & Johnson

$270.24

+1.07%

AbbVie Inc. logo

ABBV

AbbVie Inc.

$265.01

+1.21%

Merck & Co., Inc. logo

MRK

Merck & Co., Inc.

$152.55

+2.39%

UnitedHealth Group Incorporated logo

UNH

UnitedHealth Group Incorporated

$390.11

+1.37%

Novartis AG logo

NVS

Novartis AG

$158.86

+1.68%

ETFs holding DOCS

Funds reporting this stock among their holdings, ordered by reported position size.

iShares Core S&P Mid-Cap ETF logoiShares Core S&P Mid-Cap ETFIJH
Market value
113.47M
Weight
0.09%
AUM
125.92B USD
Expense ratio
0.05%
Price / 1D
$76.77+0.52%
Vanguard Morningstar Total Stock Market ETF logoVanguard Morningstar Total Stock Market ETFVTI
Market value
88.22M
Weight
0.00%
AUM
2.3T USD
Expense ratio
0.03%
Price / 1D
$378.24+0.44%
Vanguard Morningstar Small-Cap ETF logoVanguard Morningstar Small-Cap ETFVB
Market value
63.41M
Weight
0.03%
AUM
183.4B USD
Expense ratio
0.03%
Price / 1D
$304.76+0.64%
Vanguard Morningstar Small-Cap Growth ETF logoVanguard Morningstar Small-Cap Growth ETFVBK
Market value
36.85M
Weight
0.08%
AUM
43.8B USD
Expense ratio
0.05%
Price / 1D
$358.65+0.70%
Vanguard Extended Market ETF logoVanguard Extended Market ETFVXF
Market value
32.21M
Weight
0.03%
AUM
93.7B USD
Expense ratio
0.05%
Price / 1D
$245.53+0.82%
Invesco S&P MidCap Quality ETF logoInvesco S&P MidCap Quality ETFXMHQ
Market value
32.19M
Weight
0.57%
AUM
5.67B USD
Expense ratio
0.31%
Price / 1D
$119.27+0.45%
State Street SPDR S&P MIDCAP 400 ETF Trust logoState Street SPDR S&P MIDCAP 400 ETF TrustMDY
Market value
25.42M
Weight
0.10%
AUM
26.72B USD
Expense ratio
0.23%
Price / 1D
$699.6+0.48%
iShares S&P Mid-Cap 400 Growth ETF logoiShares S&P Mid-Cap 400 Growth ETFIJK
Market value
19.17M
Weight
0.17%
AUM
10.95B USD
Expense ratio
0.16%
Price / 1D
$115.45+0.37%

Continue in GoAI

Research DOCS

research.disclaimer